Posts Tagged: Kevin J Tracey

Global Good Fund, the Feinstein Institute and Sanguistat Announce New Bioelectronic Treatment Initiative to Address Bleeding

Posted

BELLEVUE, WA, MANHASSET, NY, MORRIS, CT – The Global Good Fund, The Feinstein Institute for Medical Research at Northwell Health and Sanguistat, Inc, are partnering on clinical trials of the Neural Tourniquet to evaluate the efficacy of bioelectronic medicine in treating blood loss associated with postpartum hemorrhage. “Postpartum hemorrhage is the leading cause of maternal deaths… read more

posted in: Press Releases tags:

Feinstein Institute Presents Cerami Award to Dr. Tak W. Mak for Cancer Research

Posted

Monograph focused on Dr. Mak’s research on T cell receptors and their implications in cancer and immunology will be published in Molecular Medicine MANHASSET, NY – The Feinstein Institute for Medical Research and Molecular Medicine announced today that the sixth Anthony Cerami Award in Translational Medicine will be awarded to Tak W. Mak, PhD, Director… read more

posted in: Press Releases tags:

Feinstein Institute Builds Research Administrative Team to Drive Growth

Posted

Chelico and Strand will support expansion of research units and clinical trials MANHASSET, NY – The Feinstein Institute for Medical Research has named John David Chelico, MD, MA, FACP, as vice president of research information technology and informatics and Ivar Strand, as vice president of research finance. Both Dr. Chelico and Mr. Strand have extensive… read more

posted in: Press Releases tags:

Feinstein Institute Wins Gold Electrode Award for Work in Bioelectronic Medicine

Posted

SAN FRANCISCO, CA – The Feinstein Institute for Medical Research has earned the 2016 Gold Electrode Award Most Valuable Nonprofit Organization by Neurotech Reports. The Award was given at the 2016 Neurotech Leaders Forum in San Francisco, California, and recognizes the Feinstein Institute for having the vision and the fortitude to drive the bioelectronic medicine field forward, and expand neuromodulation technologies into new indications…. read more

posted in: Press Releases tags:

Feinstein Institute Researchers Chosen for New Elite NIH Grant Program

Posted

Manhasset, NY – Two Feinstein Institute for Medical Research scientists have each been awarded five-year grants – one for 3 million and another 2 million – from the National Institutes of Health (NIH). Kevin J. Tracey, MD, Feinstein Institute president and CEO, and Ping Wang, MD, chief scientific officer, have each received this distinguished honor to continue… read more

posted in: Press Releases tags:

Feinstein Institute CEO Receives Shock Society Scientific Achievement Award

Posted

Manhasset, NY – The Feinstein Institute for Medical Research President and CEO Kevin J. Tracey, MD will be awarded the Scientific Achievement Award at the 39th Annual Conference on Shock during a dinner ceremony today. The Shock Society award, which recognizes lifetime achievements in the field of shock research, is being presented to Dr. Tracey for his… read more

posted in: Press Releases tags:

Feinstein Institute Spin-off TheraSource Receives $3 Million NIH Grant to Develop a Mitigator for Nuclear Disasters

Posted

Manhasset, NY – Feinstein Institute for Medical Research and TheraSource LLC, a Long Island-based biotech company, announced today that TheraSource has received a $3 million three-year Small Business Innovation Research (SBIR) grant from the National Institute of Allergy and Infectious Diseases (NIAID), which is part of the National Institutes of Health (NIH). The grant will support the development… read more

posted in: Press Releases tags:

Feinstein Institute Appoints David Dangoor, Scott Rechler as New Board Members

Posted

MANHASSET, NY – The Feinstein Institute for Medical Research today announced the appointment of two new members to its Board of Directors, David Dangoor and Scott Rechler. “The addition of David Dangoor and Scott Rechler strengthens our already-impressive and dedicated group of board members,” said Board Chair Barbara Hrbek Zucker. “As a board, we will continue to… read more

posted in: Press Releases tags:

Patient Advocacy Group Honors Feinstein Institute President as “Sepsis Hero”

Posted

Kevin J. Tracey, MD, president and CEO of The Feinstein Institute for Medical Research, was honored with a Sepsis Heroes Award by the Sepsis Alliance, a patient advocacy group, in recognition for his leadership role in improving understanding of sepsis. Click here to read about our initiatives in sepsis.

posted in: Press Releases tags:

New Study Published in Molecular Medicine Reports that Novel Agent Decreases Neuropathic Pain in Patients with Type 2 Diabetes

Posted

Promising profile of disease modification and pain reduction leads to proof of concept trials Manhasset, NY – Molecular Medicine, a peer-reviewed biomedical journal published by the Feinstein Institute Press, published the results of a new study reporting clinically significant pain reduction in type 2 diabetic patients. In an exploratory study conducted by Araim Pharmaceuticals, a biotech… read more

posted in: Press Releases tags: